Triton-X 100 soluble/insoluble fractions

AB Anthony R. Braun
EL Elly E. Liao
MH Mian Horvath
PK Prakriti Kalra
KA Karen Acosta
MY Malaney C. Young
NK Noah Nathan Kochen
CL Chih Hung Lo
RB Roland Brown
ME Michael D. Evans
WP William C. K. Pomerantz
ER Elizabeth Rhoades
KL Kelvin Luk
RC Razvan L. Cornea
DT David D. Thomas
JS Jonathan N. Sachs
request Request a Protocol
ask Ask a question
Favorite

HEK cells were transiently transfected with empty vector or GFP-αSN/αSN-RFP as previously described. Cells were treated with either PBS or PFF seeds (4 μg/mL) 24 h after transfection. After 24 h of treatment, cells were harvested in cold lysis buffer (50 mM Tris/HCl pH 7.4, 150 mM NaCl, 5 mM EDTA pH 8.0) with protease and phosphatase inhibitors and 1% Triton-X 100 and incubated on ice for 30 min. The lysates were then centrifuged at 25,000 × g for 60 min at 4 °C. The supernatant was collected as the Triton-X 100 soluble fraction and the pellet was resuspended in lysis buffer with 2% SDS and sonicated for 10 s and collected as the Triton-X 100 insoluble fraction. Both fractions were boiled and then a BCA protein assay was used to quantify the protein concentration of the samples. Approximately 12 μg of total protein was loaded onto a 4–20% mini-Protean TGX gel (Bio-Rad, Hercules, CA), and blots were evaluated as described previously.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A